Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ezequiel Ridruejo

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
Expert Opinion on Drug Safety|February 20, 2014
Safety of direct-acting antivirals in the treatment of chronic hepatitis CEzequiel Ridruejo
Expert Opinion on Drug Safety|December 31, 2014
Does hepatitis B virus therapy reduce the risk of hepatocellular carcinoma?Ezequiel Ridruejo
World Journal of Gastroenterology|June 27, 2014
Treatment of chronic hepatitis B in clinical practice with entecavir or tenofovirEzequiel Ridruejo
World Journal of Hepatology|March 3, 2015
Antiviral treatment for chronic hepatitis B in renal transplant patientsEzequiel Ridruejo
Annals of Hepatology|May 20, 2020
The liver in times of COVID-19: What hepatologists should knowEzequiel Ridruejo, Alejandro Soza
Expert Opinion on Drug Safety|March 16, 2012
Safety of long-term nucleos(t)ide treatment in chronic hepatitis BEzequiel Ridruejo, Marcelo O Silva
BMC Gastroenterology|August 5, 2005
Chylous ascites as the main manifestation of left ventricular dysfunction: a case reportEzequiel Ridruejo, Oscar G Mandó
Expert Review of Clinical Pharmacology|August 29, 2019
Hepatitis B virus infection as a risk factor for chronic kidney diseaseFabrizio Fabrizi, Roberta Cerutti, Ezequiel Ridruejo
Medicina|December 14, 2016
[Screening, diagnosis and treatment of chronic hepatitis C in clinical practice]Ezequiel Ridruejo, Hugo Fainboim, Alejandra Villamil
The Annals of Pharmacotherapy|June 16, 2011
Thioctic acid-induced acute cholestatic hepatitisEzequiel Ridruejo, Teresa Castiglioni, Marcelo O Silva
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Expert Opinion on Drug Safety|February 20, 2014
Safety of direct-acting antivirals in the treatment of chronic hepatitis CEzequiel Ridruejo
Expert Opinion on Drug Safety|December 31, 2014
Does hepatitis B virus therapy reduce the risk of hepatocellular carcinoma?Ezequiel Ridruejo
World Journal of Gastroenterology|June 27, 2014
Treatment of chronic hepatitis B in clinical practice with entecavir or tenofovirEzequiel Ridruejo
World Journal of Hepatology|March 3, 2015
Antiviral treatment for chronic hepatitis B in renal transplant patientsEzequiel Ridruejo
Annals of Hepatology|May 20, 2020
The liver in times of COVID-19: What hepatologists should knowEzequiel Ridruejo, Alejandro Soza
Expert Opinion on Drug Safety|March 16, 2012
Safety of long-term nucleos(t)ide treatment in chronic hepatitis BEzequiel Ridruejo, Marcelo O Silva
BMC Gastroenterology|August 5, 2005
Chylous ascites as the main manifestation of left ventricular dysfunction: a case reportEzequiel Ridruejo, Oscar G Mandó
Expert Review of Clinical Pharmacology|August 29, 2019
Hepatitis B virus infection as a risk factor for chronic kidney diseaseFabrizio Fabrizi, Roberta Cerutti, Ezequiel Ridruejo
Medicina|December 14, 2016
[Screening, diagnosis and treatment of chronic hepatitis C in clinical practice]Ezequiel Ridruejo, Hugo Fainboim, Alejandra Villamil
The Annals of Pharmacotherapy|June 16, 2011
Thioctic acid-induced acute cholestatic hepatitisEzequiel Ridruejo, Teresa Castiglioni, Marcelo O Silva
Pageof 9